-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Krystal Biotech, Raises Price Target to $396

Benzinga·07/14/2026 14:18:27
语音播报
B of A Securities analyst Alec Stranahan maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from $364 to $396.